GPT and liver disorder: American Association for Liver Disease guidelines (2018) suggest that CHB patients with obvious inflammation or fibrosis, evaluated alanine aminotransferase (ALT) above 2 × upper limit of normal (ULN) (35 IU/ml in males and 25 IU/ml in females) and evaluated HBV DNA should receive antiviral therapy [8, 9].